Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labelingCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32023-08-285OAAI
First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid TumorsCLINICAL CANCER RESEARCHIF10.22021-10-0142OAAI
Pivotal Dose of Pembrolizumab: A Dose-Finding Strategy for Immuno-OncologyCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52021-03-0819PREAI
Initial results of a phase I study of MK-4830, a first-in-class anti-immunoglobulin-like transcript 4 (ILT4) myeloid-specific antibody in patients (pts) with advanced solid tumoursANNALS OF ONCOLOGYIF65.42020-09-016OAAI
Development and validation of a multiplexed drug level assay in support of combination biologics therapy clinical studiesJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12019-07-015PREAI
Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic Modeling (vol 19, pg 510, 2017)AAPS JOURNALIF3.72017-01-170OAAI
Optimal Affinity of a Monoclonal Antibody: Guiding Principles Using Mechanistic ModelingAAPS JOURNALIF3.72016-12-2116PREAI
Novel Anti-TM4SF1 Antibody-Drug Conjugates with Activity against Tumor Cells and Tumor VasculatureMOLECULAR CANCER THERAPEUTICSIF5.52015-08-0538OAAI
Quantitative Prediction of Human Pharmacokinetics for mAbs Exhibiting Target-Mediated DispositionAAPS JOURNALIF3.72014-12-0344OAAI
Pharmacodynamic Model of Parathyroid Hormone Modulation by a Negative Allosteric Modulator of the Calcium-Sensing ReceptorAAPS JOURNALIF3.72011-03-2512OAAI
Type I Interferon Receptor is a Primary Regulator of Target-Mediated Drug Disposition of Interferon-β in MiceJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82010-07-0117OAAI
Interspecies Scaling of Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Type I InterferonsPHARMACEUTICAL RESEARCHIF4.32010-03-1640OA
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Parathyroid Hormone-Calcium Homeostasis in Rats and HumansJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82009-07-0121PREAI
Partial derivative - Based sensitivity analysis of models describing target-mediated drug dispositionAAPS JOURNALIF3.72007-06-0140OAAI